Nigel Sheail Biography

Nigel Sheail: Head, Mergers & Acquisitions and Business Development & Licensing
Novartis International AG, Basel

Nigel Sheail is Head of Mergers & Acquisitions and Business Development & Licensing since
September 1st, 2017 and joined Novartis in 2015 as Head of Business Development &
Licensing. He is a member of the Pharmaceutical Executive Committee and Financial
Leadership Team.

Prior to joining Novartis, Nigel was Head of Business Development and Licensing for Bayer
Healthcare. He also served as Head of Group M&A at Roche and Head of Licensing for their
Pharma division.

Nigel has been responsible for a broad range of healthcare deals from research and
technology collaborations through to large M&A transactions. Academically trained as a
molecular biologist, Nigel is a qualified Chartered Accountant and has held a number of
functions within the Pharmaceutical industry at Bayer, Roche and GSK.

In addition to his work in business development, Nigel has also worked as a global controller
for research and was finance director responsible for the establishment of Roche’s operations
in China which included five joint venture operating companies and a holding company. Nigel
was the founding treasurer of the Swiss Pharma Licensing Group.

Nigel holds a Bachelor of Science degree in Molecular Biology with high honors from the
University of Edinburgh, School of Biological Sciences and an ACA degree, ICAEW Chartered
Accountant qualification.